474 related articles for article (PubMed ID: 30915884)
1. The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis.
Sun Y; Wang P; Yang W; Shan Y; Zhang Q; Wu H
Cancer Biol Ther; 2019; 20(6):729-739. PubMed ID: 30915884
[TBL] [Abstract][Full Text] [Related]
2. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H
J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270
[TBL] [Abstract][Full Text] [Related]
3. Leptin-elicited miRNA-342-3p potentiates gemcitabine resistance in pancreatic ductal adenocarcinoma.
Ma L; Fan Z; Du G; Wang H
Biochem Biophys Res Commun; 2019 Feb; 509(3):845-853. PubMed ID: 30638935
[TBL] [Abstract][Full Text] [Related]
4. LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer.
Li C; Wang P; Du J; Chen J; Liu W; Ye K
IUBMB Life; 2021 Jan; 73(1):286-298. PubMed ID: 33314669
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine resistance in pancreatic cancer via upregulating TWF1.
Hua YQ; Zhu YD; Xie GQ; Zhang K; Sheng J; Zhu ZF; Ning ZY; Chen H; Chen Z; Meng ZQ; Liu LM
Aging (Albany NY); 2019 Nov; 11(20):8860-8878. PubMed ID: 31619579
[TBL] [Abstract][Full Text] [Related]
6. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
[TBL] [Abstract][Full Text] [Related]
7. SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer.
Zhang X; Zhao P; Wang C; Xin B
Biochem Biophys Res Commun; 2019 Mar; 510(4):508-514. PubMed ID: 30737032
[TBL] [Abstract][Full Text] [Related]
8. RELA/NEAT1/miR-302a-3p/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration.
Luo Z; Yi ZJ; Ou ZL; Han T; Wan T; Tang YC; Wang ZC; Huang FZ
J Cell Physiol; 2019 Apr; 234(4):3583-3597. PubMed ID: 30362505
[TBL] [Abstract][Full Text] [Related]
9. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.
Liu G; Ji L; Ke M; Ou Z; Tang N; Li Y
Biomed Pharmacother; 2018 Oct; 106():523-531. PubMed ID: 29990840
[TBL] [Abstract][Full Text] [Related]
10. LncRNA RGMB-AS1 facilitates pancreatic cancer cell proliferation and migration but inhibits cell apoptosis via miR-574-3p/PIM3 axis.
Song W; Shi C
Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G477-G488. PubMed ID: 34468207
[TBL] [Abstract][Full Text] [Related]
11. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis.
Zhang ZB; Liu N
Aging (Albany NY); 2021 Aug; 13(16):20820-20835. PubMed ID: 34461605
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MSC-AS1, as an oncogene in melanoma, promotes the proliferation and glutaminolysis by regulating the miR-330-3p/ YAP1 axis.
Tian T; Luo B; Shen G; Ji G
Anticancer Drugs; 2022 Nov; 33(10):1012-1023. PubMed ID: 36206100
[TBL] [Abstract][Full Text] [Related]
14. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
15. lncRNA
Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway.
Xu F; Huang M; Chen Q; Niu Y; Hu Y; Hu P; Chen D; He C; Huang K; Zeng Z; Tang J; Wang F; Zhao Y; Wang C; Zhao G
Cancer Res; 2021 Nov; 81(22):5678-5691. PubMed ID: 34593522
[TBL] [Abstract][Full Text] [Related]
17. CDK14/β-catenin/TCF4/miR-26b positive feedback regulation modulating pancreatic cancer cell phenotypes in vitro and tumor growth in mice model in vivo.
Sun Y; Wang P; Zhang Q; Wu H
J Gene Med; 2022 Feb; 24(2):e3343. PubMed ID: 33871149
[TBL] [Abstract][Full Text] [Related]
18. LncRNA IGFL2-AS1 as a ceRNA Promotes HCT116 Cell Malignant Proliferation via the miR-433-3p/PAK4 Axis.
Liu S; Wang X; Zhang J; Liu Y; Li B
Turk J Gastroenterol; 2023 May; 34(5):497-507. PubMed ID: 36620931
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA FOXD3-AS1 silencing exerts tumor suppressive effects in nasopharyngeal carcinoma by downregulating FOXD3 expression via microRNA-185-3p upregulation.
Hu J; Pan J; Luo Z; Duan Q; Wang D
Cancer Gene Ther; 2021 Jun; 28(6):602-618. PubMed ID: 33204001
[TBL] [Abstract][Full Text] [Related]
20. LncRNA BBOX1-AS1 Contributes to the Progression of Esophageal Carcinoma by Targeting the miR-361-3p/COL5A1 Axis.
Lu YH; He DS; Li Y; Wang H; Ma RD
Biochem Genet; 2023 Aug; 61(4):1351-1368. PubMed ID: 36586008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]